From: Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
CSF donors database | Serum donors database | |||
---|---|---|---|---|
AD (n = 41) | Control (n = 23) | AD (n = 36) | Control (n = 24) | |
Age, y median (IQR) | 68 (66–72) | 69 (63–73) | 68 (66–70) | 70 (64–72) |
Sex, f/m (% f/m) | 29/12 (70.7) | 13/10 (56.5) | 25/11 (69.4) | 12/12 (50.0) |
MMSE, median (IQR) | 21.5 (17.0–24.0)* | 29.0 (n = 12) (28.0–30.0) | 21.0 (17.0–23.5)* | 29.0 (n = 14) (28.0–30.0) |
CSF Aβ42 (pg/ml), median (IQR) | 472.0 (367.0–569.0)* | 1014.0 (n = 14) (875.8–1191.8) | 476.0 (373.8–577.3)* | 1014.0 (n = 14) (875.8–1191.8) |
CSF T-tau (pg/ml), median (IQR) | 616.0 (371.0–1009.0)* | 228.0 (n = 14) (204.8–279.8) | 659.0 (412.8–1129.0)* | 228.0 (n = 14) (204.8–279.8) |